Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$63.84 – $184.09
14% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.59B | $8.54B | $9.10B | $10.27B | $10.49B | $13.17B | $14.80B | $15.43B |
| Cost of revenue | $2.60B | $3.76B | $3.92B | $4.47B | $4.83B | $6.47B | $7.13B | $7.48B |
| Gross profit | $2.99B | $4.78B | $3.59B | $5.74B | $5.66B | $6.71B | $7.56B | $7.95B |
| Gross margin | 53.5% | 56.0% | 39.4% | 55.9% | 54.0% | 50.9% | 51.1% | 51.5% |
| R&D | $517.0M | $831.8M | $638.7M | $751.8M | $1.16B | $1.24B | $1.45B | $1.36B |
| Operating income | $1.76B | $2.10B | $1.89B | $2.59B | $2.92B | $2.90B | $3.81B | $2.96B |
| EBITDA | $1.98B | $2.81B | $3.14B | $3.63B | $3.46B | $3.90B | $4.73B | $5.13B |
| Net income | $1.27B | $1.92B | $1.46B | $1.78B | $2.25B | $2.19B | $2.64B | $3.00B |
| Net margin | 22.8% | 22.5% | 16.0% | 17.4% | 21.5% | 16.7% | 17.9% | 19.5% |
| EPS (diluted) | 2.80 | 4.23 | 3.20 | 3.93 | 4.80 | 4.53 | 5.45 | 6.17 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $15.6B | $6.40 | $6.08–$6.85 | 1 |
| 2028 | $16.2B | $6.84 | $6.49–$7.32 | 1 |
| 2029 | $16.6B | $7.00 | $6.64–$7.49 | 1 |
Forward consensus · source: Financial Modeling Prep
CSL LTD
No one on the platform currently holds CMXHF.
No tracked institution reports a position in CMXHF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2007-10-18 | 3-for-1 |
No one on the platform has traded CMXHF yet.
| $61.5B |
| — |
| MKGAFMerck KGaA | $165.91 | -2.41% | $72.1B | — |
| MKKGYMerck KGaA | $32.96 | -1.70% | $71.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 8.3× earnings vs its 39.9× historical median P/E.
Fair value ≈ $387.07 · price $80.14 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.